Sarah Sedik
@SarahSedik
Followers
27
Following
34
Media
2
Statuses
18
Joined October 2023
🧫 Persistent candidemia: lessons from a European cohort In 258 patients from 18 countries, 20% had ≥5 days of (+) cultures → higher mortality (50% vs 32%). Low EQUAL #Candida Scores predicted persistence 💡 Adherence saves lives 🔗 https://t.co/Nx4atkp8i5
3
16
29
GALActIC Project – EU Collaboration Against IAPA | Consortium Meeting on Future Planning in Bilbao 🇪🇸 @Galactic_europe
@martinhoenigl
@s_feys
@carvalho_ago
@Stella_A_I Joost Wauters Marius Huguet Frank Van de Veerdonk Jannes Heylen
0
5
12
Climate change: shifting boundaries of fungal disease in Europe and beyond. @NormanRhijn @SarahSedik
https://t.co/rOBSkQVJHV
0
9
20
Was a great pleasure to work on this with colleagues and frieds from @MSG_ERC Thanks to @SarahSedik for the figures. Diagnosis and Management of Candida Endophthalmitis and Chorioretinitis - Clinical Microbiology and Infection
0
12
20
First retreat of our translational mycology working group 🍄👨🏼💻👩💻 Shaping future research topics and study designs in medical mycology 🦾 @martinhoenigl @SarahSedik @Stella_A_I
0
3
13
Exciting news! The ECMM Candida IV study is now featured on the ECMM website! Find all the details here: https://t.co/XAsWJjEjO1 @martinhoenigl @Stella_A_I @SarahSedik
ecmm.info
ECMM Candida IV Antifungal tolerance, resistance and clinical outcomes on candidemia caused by non-albicans Candida Observation periods/Timeline Observation period: April 1st, 2024 – September 30th,...
0
6
9
🎉 Exciting news from #ESCMIDGlobal2025! Proud to present our ECMM Candida IV study Poster at #ESCMID2025! Great discussions and inspring feedback - thanks to everyone who stopped by! #Candida #ClinicalResearch #ESMID #PosterPresentation #Oraltalk
0
5
10
Join our Global ECMM Candida IV Study 🍄 @eurconfmedmycol
@EcmmCandidaIV
@martinhoenigl
@Stella_A_I
#ESCMIDGlobal2025
3
6
16
@SarahSedik presenting difficult to treat fungal infections at #ESCMIDGlobal2025 in Vienna. 😎🍄 New antifungals = new hope for our severely ill patients 🦾
0
5
5
ECMM Candida IV Study is still open for participation Global study on non-albicans candidemia Requirements: 🔬Clinical data + isolates (no limit per site) 📅Apr 2024-Sep 2025 📦Ship isolates in one batch at study end 💰Case-based reimbursement available @eurconfmedmycol
2
6
9
👉Participate in @eurconfmedmycol ECMM Candida IV Study 🌍wide study on candidemia caused by non-albicans Candida Requirement: clinical data & isolate (not req for C.auris) Observation period: 04/2024 - 09/2025 Interested? DM @Stella_A_I or @SarahSedik
1
12
22
New Medical Study Starting Soon 🔬 The logo was designed in collaboration with Galactic Partners, with professional support from Esra Sedik. Follow us for more! @martinhoenigl @SarahSedik @Stella_A_I
@carvalho_ago @s_feys @eurconfmedmycol
@MSG_ERC @UZLeuven @MedUniGraz
0
4
6
🔥📰Review on "Climate Change and Medical Mycology" Congrats to @SarahSedik and @MatthiasEgger11 for great figures, tables and content! 🙏to the editors for the invite Full access here https://t.co/4gxOCQDlr1
0
34
53
Insights from 3 Pan‑European Multicentre Studies on Invasive Candida Infections and Outlook to @eurconfmedmycol Candida IV Non-albicans species on the rise! Stella Wolfgruber @SarahSedik @neil_gow @lagrou_katrien @JacquesMeis @CornelyOliver @GangneuxJp
https://t.co/7ZajGiHwVR
link.springer.com
Mycopathologia - Invasive candidiasis and candidemia remain a significant public health concern. The European Confederation of Medical Mycology (ECMM) conducted three pan-European multicentre...
1
10
24
Diagnosing fungal infections in clinical practice: a narrative review: Expert Review of Anti-infective Therapy: Vol 0 , No ja - Get Access https://t.co/9eNHrZgKbl
@martinhoenigl @krielisa_ @Stella_A_I @tandfeducation
tandfonline.com
Invasive fungal infections (IFI) present a major medical challenge, with an estimated 6.5 million cases annually, resulting in 3.8 million deaths. Pathogens such as Aspergillus spp. Candida spp. Mu...
0
7
14
Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid @SarahSedik @jprattes @MatthiasEgger11 @SpringerMicBio
https://t.co/G4gQudEyJ5
link.springer.com
Mycopathologia - Galactomannan (GM) testing using Platelia Aspergillus enzyme immunoassay (Platelia AGM) from bronchoalveolar lavage fluid (BALF) aids in early diagnosis of invasive pulmonary...
0
7
28
What a wonderful opportunity working with international fungal experts in Barcelona!
0
5
28